Worlds to Appeal to Federal Circuit on PTAB Rulings, Claims
Investor Group Exercises Warrants to Fund Appeal, Ongoing Operations
USPTO Review Validates 6 Worlds Inc. Patent Claims for Multi-Player Online Gaming Technology
BOSTON, MA — (Marketwired) — 12/01/16 — The U.S. Patent & Trademark Office (USPTO) has validated six patent claims by Inc. (OTCQB: WDDD) following Patent Trial and Appeal Board (PTAB) review of World–s seminal technology that has been fundamental to the development of (MMORPG) into a $20-billion dollar industry. Validated claims were: Claims 4, 8, 13, and 16 of Patent 7,181,690 B1 – IPR2015-01268 and claims 5 and 7 of Patent 7,493,558 B2 – IPR2015-01269.As previously announced, Worlds
Worlds Responds to Bungie Inter Partes Review Petition With the USPTO Patent Trial & Appeal Board
BOSTON, MA — (Marketwired) — 03/16/16 — (OTCQB: WDDD) has filed replies to the six Inter Partes Reviews (IPRs) instituted by the United States Patent & Trademark Office–s (USPTO) Patent Trial and Appeal Board (PTAB) at the request of petitioner Bungie Inc. The Worlds patents subject to the IPRs are also at the center of a patent infringement filed by Worlds against Activision Blizzard Inc. et al. According to the , Bungie Inc. has a multi-year contract with Activision and Activision h
Power Conversion Technology From Semitrex Approved as Patentable Worldwide
Highly-Efficient Muxcapacitor Technology Noted as –Special, New and Unique– by U.S. Patent and Trademark Office
Open-IX Association Secures Registered Trademark for “OPEN-IX(R)”
Designation Further Validates OPEN-IX(R) Brand While Protecting the Integrity of Its Data Center and Interconnection Standards
MMRGlobal Biotech Assets in Play as Company Is Awarded Second U.S. Cancer Fighting Patent
LOS ANGELES, CA — (Marketwired) — 02/02/15 — (OTCQB: MMRF) ("MMR"), a leading provider of (PHRs), storage solutions and electronic document management and imaging systems for , today announced that U.S. Patent No. 8,945,550 will issue on February 3, 2015, providing the second U.S. patent, in addition to patents in Australia, Mexico and South Korea, for the Company–s anti-CD20 monoclonal antibody technology. MMR also announced that it is in talks to sell more than 2,000 patient
MMRGlobal Subsidiary Receives Favorable Appellate Court Order Pertaining to MyMedicalRecords, Inc. $30 Million License Agreement
LOS ANGELES, CA — (Marketwired) — 12/09/14 — (OTCQB: MMRF), through its wholly owned subsidiary, MyMedicalRecords, Inc. (collectively, "MMR"), today announced that on Friday, December 5, 2014, the California Court of Appeal issued an Alternative Writ of Mandate, finding the trial court "erred in granting [Surgery Center Management, LLC–s ("SCM")] motion for summary adjudication". The Company believes that the Court of Appeal–s Alternative Order shall soon cle
Worlds Announces Private Placement, Response to Activision Lawsuit, Update on MSJ Hearing
BOSTON, MA — (Marketwired) — 10/25/13 — (OTCBB: WDDD) has commenced a private placement of non-convertible debt with some of the company-s largest shareholders. The non-dilutive financing structure does not include warrants and is expected to provide Worlds with sufficient capital for its ongoing operating needs through the anticipated Markman hearing and beyond."The favorable response to the financing by some of our largest shareholders speaks to their ongoing support of Worlds and th
Article One Partners Announces Marshall Phelps as Chief Executive Officer
Previously Director, Phelps Moves to New Position to Guide Company Through Next Stage of Growth
MMRGlobal Receives Additional Biotech Patent Protection in U.S., Mexico and Japan for Cancer Vaccines
LOS ANGELES, CA — (Marketwired) — 10/02/13 — (OTCQB: MMRF) ("MMR"), a leading provider of (PHRs), storage solutions and electronic document management and imaging systems for , today announced that two additional patents will be granted for its B-cell vaccine technologies. MMR has been notified it will receive another U.S. patent protecting methods of making compositions for B-cell vaccines pursuant to a Notice of Allowance from the United States Patent and Trademark Office. The